ArticleRSC advances2023
Development of NaY
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Pr³⁺ Activated NaY₉Si₆O₂₆ Nanophosphors With Tunable Visible Emission and High Thermal Stability for Solid-state Lightning.Journal of fluorescence · 2026Article
- Nanosized EuNanomaterials (Basel, Switzerland) · 2024Article
- Comprehensive Review on Downconversion/Downshifting Silicate-Based Phosphors for Solar Cell Applications.ACS omega · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Near-infrared (NIR) radiation has generated considerable industrial and research interest. However, NIR phosphors for this are limited by low quantum efficiency and broad spectra. Rare-earth-containing compounds doped with activators as host systems for NIR phosphors may resolve these limitations. Yb
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.